INSIGHTS ON DRUG DEVELOPMENT

• Cross-Site Work Within Cambrex's Network

  Matthew Zart, Group Leader of Analytical Development, on what happens when a method arrives from another site — inheriting Phase II work from High Point and getting it commercial-ready for the QC lab.

• Validating Antibodies With Knock-Out Technologies

  Watch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.

• Viral Gene Therapy: Reducing Costs To Improve Patient Access

  Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.

• NGS Identification Of Internal Tandem Duplications In FLT3

  Accurately identifying genetic duplications in leukemia requires more than conventional sequencing. See how advanced enrichment and analysis approaches enable deeper insight into variant structure.

• Advancing Cell Culture Strategies To Accelerate Biologics Development

  5/5/2026

  Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.

• Patient-Centric Formulations In Pediatric Adherence

  11/13/2025

  Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

• Simplify And Streamline Method Development With In Silico Modeling

  5/19/2026

  Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.

• Take Action On PFAS To Protect Your Critical Processes

  9/18/2025

  PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.

• In Vitro Drug Screening On Cancer Cells

  10/29/2025

  Explore a high-throughput assay combining stain-free imaging and multiplexed viability/toxicity measurements to evaluate drug effects on cancer cells, ideal for labs optimizing cell-based screening.